| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |